0000899243-23-016073.txt : 20230620 0000899243-23-016073.hdr.sgml : 20230620 20230620205246 ACCESSION NUMBER: 0000899243-23-016073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230615 FILED AS OF DATE: 20230620 DATE AS OF CHANGE: 20230620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTMAN MICHAEL SETH CENTRAL INDEX KEY: 0001746738 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39434 FILM NUMBER: 231027184 MAIL ADDRESS: STREET 1: C/O PERCEPTIVE ADVISORS STREET 2: 51 ASTOR PLACE, 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc. CENTRAL INDEX KEY: 0001808805 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 981541723 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-333-2001 MAIL ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III DATE OF NAME CHANGE: 20200408 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-15 0 0001808805 Nautilus Biotechnology, Inc. NAUT 0001746738 ALTMAN MICHAEL SETH 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 1 0 0 0 0 Stock Option (Right to Buy) 3.97 2023-06-15 4 A 0 45000 0.00 A 2033-06-15 Common Stock 45000 45000 D Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date. /s/ Samuel M. Cohn, Attorney-in-Fact 2023-06-20